Literature DB >> 31832864

Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell culture.

Nobuyuki Kato1, Youki Ueda2, Hiroe Sejima2, Weilin Gu2, Shinya Satoh2, Hiromichi Dansako2, Masanori Ikeda3, Kunitada Shimotohno4.   

Abstract

The most characteristic feature of the hepatitis C virus (HCV) genome in patients with chronic hepatitis C is its remarkable variability and diversity. To better understand this feature, we performed genetic analysis of HCV replicons recovered from two human hepatoma HuH-7-derived cell lines after 1, 3, 5, 7, and 9 years in culture: The cell lines 50-1 and sO harbored HCV 1B-1 and O strain-derived HCV replicons established in 2002 and 2003, respectively. The results revealed that genetic variations in both replicons accumulated in a time-dependent manner at a constant rate despite the maintenance of moderate diversity (less than 1.8% difference) between the clones and that the mutation rate in the 50-1 and sO replicons was 2.5 and 2.9 × 10-3 base substitutions/site/year, respectively. We found that the genetic distance of both replicons increased from 7.9% to 10.5% after 9 years in culture. In addition, we observed that the guanine + cytosine (GC) content of both replicon RNAs increased in a time-dependent manner, as observed in our previous studies. Finally, we demonstrated that the high sensitivity of both replicons to direct-acting antivirals was maintained even after 9 years in culture. Our results suggest that long-term cultured HCV replicon-harboring cells are a useful model for understanding the variability and diversity of the HCV genome and the drug sensitivity of HCV in patients with chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31832864     DOI: 10.1007/s00705-019-04461-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  2 in total

1.  Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing.

Authors:  Fumiyasu Nakamura; Haruhiko Takeda; Yoshihide Ueda; Atsushi Takai; Ken Takahashi; Yuji Eso; Soichi Arasawa; Eriko Iguchi; Takahiro Shimizu; Masako Mishima; Ken Kumagai; Taiki Yamashita; Shinji Uemoto; Nobuyuki Kato; Hiroyuki Marusawa; Akihiro Sekine; Hiroshi Seno
Journal:  Sci Rep       Date:  2022-04-30       Impact factor: 4.996

2.  Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities.

Authors:  Weilin Gu; Youki Ueda; Hiromichi Dansako; Shinya Satoh; Nobuyuki Kato
Journal:  FASEB Bioadv       Date:  2021-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.